Meet us @ BioEurope 2016

  We will be attending BioEurope 2016, April 4-6, 2016 I Stockholm, Sweden. You can ask for a meeting through partneringONE® or by sending a message to humanhealth@medincell.com. Click here for more details about BioEurope 2016.

Read more

Meet us @ 6th Annual Strategic Alliance Management for Pharma

http://www.marcusevans-conferences-paneuropean.com/ahtml/marcusevans-conferences-event-details.asp?EventID=22555

Read more

MedinCell enters into a technology agreement for long-acting injectable products

MedinCell and Sandoz will develop and commercialize long-acting injectable products based on BEPO™ technology with a primary focus on oncology The alliance is part of MedinCell’s network strategy to significantly improve current standard of care, reduce total costs to payers and therefore make treatments widely available worldwide MedinCell, a leading innovator developing best in class enabling […]

Read more

Postoperative pain management with BEPO™

First results of our scientific collaboration with Lapeyronie University Hospital, Dept of Anaesthesiology & Intensive Care and Montpellier University (INSERM U1046) about pospoperative pain management based on bupivacaine BEPO™ formulation were presented last week at Anesthesiology2015 in San Diego. Here is the poster. click image to enlarge  

Read more

Corbion and MedinCell form joint venture to supply resorbable polymers for controlled drug release

Corbion and MedinCell are establishing a 50/50 joint venture for the supply of PEG (polyethyleneglycol) and PLA (polylactic acid) based co-polymers in the field of controlled release drug delivery. The joint venture, CM Biomaterials, will sell the PEG / PLA co-polymers to MedinCell partners who license the MedinCell technology (BEPO™). Manufacturing of the polymers will […]

Read more